Jason Spangler, MD, MPH, FACPM
For nearly two decades, Dr. Spangler, Center for Innovation & Value Research Chief Executive Officer, has worked in the professional health policy and public health sector with pharmaceutical and non-profit organizations. Dr. Spangler joins the Center from his most recent role as Executive Medical Director and Director and Head of Global HTA Policy Strategy & […]
Ilisa Halpern Paul, MPP
Ilisa Halpern Paul is a senior policy advisor at Venable LLP in the firm’s Washington, DC office. Ilisa co-leads the firm’s Federal Health Policy team, drawing on more than 30 years of recorded success in helping established and start-up healthcare companies, health and hospital systems, provider associations, and nonprofit patient advocacy organizations advance their legislative, […]
Eberechukwu Onukwugha, MS, PhD
Eberechukwu Onukwugha, PhD is a Professor in the Department of Practice, Sciences, and Health Outcomes Research at the University of Maryland School of Pharmacy and is the Executive Director of Pharmaceutical Research Computing at the University of Maryland School of Pharmacy. She received a Bachelor of Arts in economics and French from the University at […]
Kistein Monkhouse, MPA
Kistein Monkhouse, a public health advocate and former frontline healthcare worker, is the founder of Patient Orator, a digital platform aiming to improve patient-provider communication and tackle health disparities. Her work extends to award-winning documentary production, including “Humanizing Health Care” and “The Cost of Abortion Bans.” Beyond entrepreneurship, Monkhouse actively contributes to various not-for-profit boards, […]
Meng Li, PhD
Dr. Li received her ScM in Epidemiology from Johns Hopkins University and her PhD in Pharmaceutical Outcomes Research & Policy from University of Washington. She completed a two-year postdoctoral fellowship at the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California. Her research interests include defining and measuring novel […]
Bellinda King-Kallimanis, PhD
Bellinda is Senior Director of Patient-Focused Research at LUNGevity Foundation. In her work at LUNGevity she aims to ensure that patient and caregiver voices are incorporated in decision making across a wide variety of stakeholders and has built a Citizen Scientist program to aid this. Prior to joining LUNGevity, she worked at the US Food […]
Annie Kennedy
A veteran leader in the rare disease patient focused drug development movement, Annie joined the EveryLife Foundation in 2018, where she’s led the Cost of Delayed Diagnosis: A Health Economic Study, the National Economic Burden of Rare Disease study, the development of the ICD Code Roadmap, and the community-driven Guide to Patient Involvement in Rare […]
Sneha Dave
Sneha graduated from Indiana University in May 2020 where she majored in chronic illness advocacy as well as journalism. She created Generation Patient to develop support systems for adolescents and young adults with chronic conditions across the U.S. and internationally. She is proud to work with a team composed of entirely young adults with chronic […]
Rick Chapman, PhD
Rick Chapman brings decades of health economics and outcomes research (HEOR) expertise to his role as Chief Science Officer. Chapman was Director of Health Economics at the Institute for Clinical and Economic Review prior to the Center for Innovation & Value Research, where he led development of economic evaluations that accompanied rigorous reviews of clinical […]
Jon Campbell, MS, PhD
Jon Campbell, MS, PhD, is the Chief Science Officer (CSO) of the National Pharmaceutical Council (NPC), which sponsors and conducts research on health policy issues related to the development and use of innovative biopharmaceuticals to improve the health of patients. NPC’s research contributes to the body of evidence that supports discussions and decisions about patient […]